Comparison

Daclatasvir dihydrochloride (BMS-790052)

Item no. DCC-DC7394-100mg
Manufacturer DCChemicals
CASRN 1009119-65-6
Amount 100 mg
Quantity options 100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category
Type Inhibitors
Applications Cell Culture
Specific against other
Purity >99%
Smiles O=C([C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])N([H])C(=O)OC([H])([H])[H])N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C1=NC([H])=C(C2C([H])=C([H])C(=C([H])C=2[H])C2C([H])=C([H])C(=C([H])C=2[H])C2=C([H])N=C([C@]3([H])C([H])([H])C([H])([H])C([H])([H])
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias BMS-790052,BMS790052 ,BMS 790052,Daclatasvir
Similar products 1009119-65-6
Available
Manufacturer - Applications
Daclatasvir (BMS-790052) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture.
Storage Conditions
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight
738, 875
Note
For research only, not for human use!
Chemical name
Carbamic acid, N, N'-[[1, 1'-biphenyl]-4, 4'-diylbis[1H-imidazole-5, 2-diyl-(2S)-2, 1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2, 1-ethanediyl]]]bis-, C, C'-dimethyl ester

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close